| [1] |
张红宇. 周围静脉畸形的诊断、分型与治疗[D]. 郑州大学, 2016.
|
| [2] |
Buckmiller LM, Richter GT, Suen JY. Diagnosis and management of hemangiomas and vascular malformations of the head and neck[J]. Oral Diseases, 2010, 16(5): 405-418.
|
| [3] |
Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche[J]. Cell, 2004, 118(2): 149-161.
|
| [4] |
Palma MD, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors[J]. Cancer Cell, 2005, 8(3): 211-226.
|
| [5] |
Vikkula M, Boon LM, Iii K, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase Tie2[J]. Cell, 1996, 87(7): 1181-1190.
|
| [6] |
Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations[J]. Nature Genetics, 2009, 41(1): 118-124.
|
| [7] |
Soblet J, Limaye N, Uebelhoer M, et al. Variable somatic Tie2 mutations in half of sporadic venous malformations[J]. Mol Syndromol, 2013, 4(4): 179-183.
|
| [8] |
Wouters V, Limaye N, Uebelhoer M, et al. Hereditary cutaneomucosal venous malformations are caused by Tie2 mutations with widely variable hyper-phosphorylating effects[J]. European Journal of Human Genetics, 2010, 18(4): 414-420.
|
| [9] |
Calvert JT, Riney TJ, Kontos CD, et al. Allelic and locus heterogeneity in inherited venous malformations[J]. Human Molecular Genetics, 1999(7): 1279-1289.
|
| [10] |
Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system[J]. Nat Rev Mol Cell Biol, 2009, 10(3): 165-177.
|
| [11] |
Eklund L, Saharinen P. Angiopoietin signaling in the vasculature[J]. Exp Cell Res, 2013, 319(9): 1271-1280.
|
| [12] |
Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning[J]. Cell, 1997, 87(7): 1161-1169.
|
| [13] |
Dumont DJ, Yamaguchi TP, Conlon RA, et al. TEK, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors[J]. Oncogene, 1992, 7(8): 1471.
|
| [14] |
Sato TN, Qin Y, Kozak CA, et al.Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system[J]. Proc Natl Acad Sci U S A, 1993, 90(20): 9355-9358.
|
| [15] |
Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis[J]. Cell, 1996, 87(7): 1171-1180.
|
| [16] |
Dumont DJ, Gradwohl G, Fong GH, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, TEK, reveal a critical role in vasculogenesis of the embryo[J]. Genes Dev, 1994, 8(16): 1897-1909.
|
| [17] |
Jeansson M, Gawlik A, Anderson G, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury[J]. Journal of Clinical Investigation, 2011, 121(6): 2278-2289.
|
| [18] |
Ye C, Pan L, Huang Y, et al. Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations[J]. Journal of Vascular Surgery, 2011, 54(6): 1760-1768.
|
| [19] |
Boscolo E, Limaye N, Huang L, et al. Rapamycin improves Tie2-mutated venous malformation in murine model and human subjects[J]. Journal of Clinical Investigation, 2015, 125(9): 3491-3504.
|